Skip navigation

Refine by Type

Results 1 - 10 of 10 for glatiramer
  1. Glatiramer is used to reduce episodes of symptoms in patients with relapsing-remitting multiple sclerosis. Glatiramer is in a class of medications called immunomodulators. ...
  2. Travelers' Health: Immunocompromised Travelers (Centers for Disease Control and Prevention)  
    ... for people being treated with an interferon medication, glatiramer acetate, mitoxantrone, fingolimod, or natalizumab, although efficacy data ... listed in Table 8-02 . However, patients on glatiramer acetate and interferons have more limited immune deficits. ...
  3. Multiple Sclerosis: Hope through Research From the National Institutes of Health (National Institute of Neurological Disorders and Stroke)  
    ... symptoms, doctors may switch treatment to alternative drugs. Glatiramer acetate is another injectable immune-modulating drug used ... immune cells in the body. Side effects with glatiramer acetate are usually mild, but it can cause ...
  4. MS Disease-Modifying Medications (National Multiple Sclerosis Society) - PDF  
    ... subcutaneous (under the skin) injection; 250 mcg. Copaxone ® (glatiramer acetate) Every day; subcutaneous (under the skin) injection; ... basis. Copaxone® Warnings The FDA labeling for Copaxone (glatiramer acetate) contains the following warnings: Approximately 16% of ...
  5. National Multiple Sclerosis Society (National Multiple Sclerosis Society)  
    ... More FDA Approves a Generic Form of Copaxone® (Glatiramer Acetate) For Relapsing MS – Date of availability/price ...
  6. ... News) -- The first U.S. generic version of Copaxone (glatiramer acetate injection) has been approved by the Food ...
  7. Research News (National Multiple Sclerosis Society)  
    ... here. FDA Approves a Generic Form of Copaxone® (Glatiramer Acetate) For Relapsing MS – Date of availability/price ...
  8. Multiple Sclerosis (American Academy of Family Physicians)  
    ... side effects include flu-like symptoms and depression. Glatiramer acetates are thought to block the cells that ...
  9. Clinical Trials for Dry AMD (Macular Degeneration Partnership)  
    ... the eye every three months. Read More… Copaxone (Glatiramer Acetate) – Not Recruiting This small trial of 30 ...
  10. ... adalimumab (Humira); cyclosporine (Gengraf, Neoral, Sandimmune); etanercept (Enbrel); glatiramer (Copaxone); infliximab (Remicade); interferon beta (Avonex, Betaseron, Rebif); ...